nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—CYP2D6—breast cancer	0.117	0.389	CbGaD
Buspirone—CYP3A4—breast cancer	0.1	0.334	CbGaD
Buspirone—ABCB1—breast cancer	0.0834	0.278	CbGaD
Buspirone—HTR2B—Raloxifene—breast cancer	0.0542	0.116	CbGbCtD
Buspirone—CYP3A5—Lapatinib—breast cancer	0.0227	0.0486	CbGbCtD
Buspirone—ABCB1—Toremifene—breast cancer	0.0203	0.0434	CbGbCtD
Buspirone—CYP3A4—Exemestane—breast cancer	0.0175	0.0375	CbGbCtD
Buspirone—CYP2D6—Idarubicin—breast cancer	0.0158	0.0339	CbGbCtD
Buspirone—CYP3A7—Tamoxifen—breast cancer	0.0152	0.0324	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0152	0.0324	CbGbCtD
Buspirone—CYP3A4—Letrozole—breast cancer	0.0149	0.0319	CbGbCtD
Buspirone—ABCB1—Lapatinib—breast cancer	0.0148	0.0316	CbGbCtD
Buspirone—CYP3A4—Anastrozole—breast cancer	0.0133	0.0284	CbGbCtD
Buspirone—CYP3A4—Toremifene—breast cancer	0.0122	0.026	CbGbCtD
Buspirone—CYP3A7—Paclitaxel—breast cancer	0.0118	0.0253	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0118	0.0253	CbGbCtD
Buspirone—CYP3A7—Irinotecan—breast cancer	0.0117	0.0249	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0117	0.0249	CbGbCtD
Buspirone—CYP3A5—Tamoxifen—breast cancer	0.0114	0.0243	CbGbCtD
Buspirone—CYP3A4—Fulvestrant—breast cancer	0.0113	0.0242	CbGbCtD
Buspirone—CYP3A4—Thiotepa—breast cancer	0.0101	0.0215	CbGbCtD
Buspirone—CYP3A4—Ixabepilone—breast cancer	0.00921	0.0197	CbGbCtD
Buspirone—CYP3A4—Lapatinib—breast cancer	0.00887	0.019	CbGbCtD
Buspirone—CYP3A5—Paclitaxel—breast cancer	0.00886	0.0189	CbGbCtD
Buspirone—CYP3A5—Irinotecan—breast cancer	0.00874	0.0187	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00854	0.0183	CbGbCtD
Buspirone—CYP3A7—Docetaxel—breast cancer	0.00854	0.0183	CbGbCtD
Buspirone—ABCB1—Vinorelbine—breast cancer	0.00821	0.0175	CbGbCtD
Buspirone—CYP2D6—Vinorelbine—breast cancer	0.00774	0.0165	CbGbCtD
Buspirone—ABCB1—Tamoxifen—breast cancer	0.00741	0.0158	CbGbCtD
Buspirone—ABCB1—Mitoxantrone—breast cancer	0.00723	0.0154	CbGbCtD
Buspirone—CYP2D6—Tamoxifen—breast cancer	0.00698	0.0149	CbGbCtD
Buspirone—CYP3A4—Raloxifene—breast cancer	0.00672	0.0144	CbGbCtD
Buspirone—CYP3A5—Docetaxel—breast cancer	0.00641	0.0137	CbGbCtD
Buspirone—ABCB1—Gemcitabine—breast cancer	0.00638	0.0136	CbGbCtD
Buspirone—ABCB1—Paclitaxel—breast cancer	0.00577	0.0123	CbGbCtD
Buspirone—ABCB1—Irinotecan—breast cancer	0.00569	0.0122	CbGbCtD
Buspirone—ABCB1—Vinblastine—breast cancer	0.00506	0.0108	CbGbCtD
Buspirone—CYP3A4—Vinorelbine—breast cancer	0.00492	0.0105	CbGbCtD
Buspirone—CYP2D6—Vinblastine—breast cancer	0.00477	0.0102	CbGbCtD
Buspirone—CYP3A4—Tamoxifen—breast cancer	0.00444	0.00949	CbGbCtD
Buspirone—CYP3A4—Mitoxantrone—breast cancer	0.00433	0.00925	CbGbCtD
Buspirone—ABCB1—Docetaxel—breast cancer	0.00417	0.00891	CbGbCtD
Buspirone—CYP3A4—Paclitaxel—breast cancer	0.00346	0.00739	CbGbCtD
Buspirone—CYP3A4—Irinotecan—breast cancer	0.00341	0.00729	CbGbCtD
Buspirone—ABCB1—Doxorubicin—breast cancer	0.00311	0.00664	CbGbCtD
Buspirone—CYP3A4—Vinblastine—breast cancer	0.00303	0.00648	CbGbCtD
Buspirone—ABCB1—Methotrexate—breast cancer	0.00301	0.00644	CbGbCtD
Buspirone—CYP2D6—Doxorubicin—breast cancer	0.00293	0.00626	CbGbCtD
Buspirone—CYP3A4—Docetaxel—breast cancer	0.0025	0.00534	CbGbCtD
Buspirone—CYP3A4—Doxorubicin—breast cancer	0.00186	0.00398	CbGbCtD
Buspirone—Tinnitus—Methotrexate—breast cancer	4.42e-05	0.000261	CcSEcCtD
Buspirone—Tachycardia—Capecitabine—breast cancer	4.41e-05	0.000261	CcSEcCtD
Buspirone—Hypoaesthesia—Epirubicin—breast cancer	4.41e-05	0.000261	CcSEcCtD
Buspirone—Sweating—Doxorubicin—breast cancer	4.38e-05	0.000259	CcSEcCtD
Buspirone—Urticaria—Paclitaxel—breast cancer	4.38e-05	0.000259	CcSEcCtD
Buspirone—Hyperhidrosis—Capecitabine—breast cancer	4.37e-05	0.000259	CcSEcCtD
Buspirone—Hypotension—Docetaxel—breast cancer	4.36e-05	0.000258	CcSEcCtD
Buspirone—Body temperature increased—Paclitaxel—breast cancer	4.36e-05	0.000258	CcSEcCtD
Buspirone—Epistaxis—Doxorubicin—breast cancer	4.31e-05	0.000255	CcSEcCtD
Buspirone—Anorexia—Capecitabine—breast cancer	4.31e-05	0.000255	CcSEcCtD
Buspirone—Vomiting—Mitoxantrone—breast cancer	4.3e-05	0.000254	CcSEcCtD
Buspirone—Vomiting—Irinotecan—breast cancer	4.3e-05	0.000254	CcSEcCtD
Buspirone—Dizziness—Fluorouracil—breast cancer	4.28e-05	0.000253	CcSEcCtD
Buspirone—Rash—Irinotecan—breast cancer	4.26e-05	0.000252	CcSEcCtD
Buspirone—Rash—Mitoxantrone—breast cancer	4.26e-05	0.000252	CcSEcCtD
Buspirone—Dermatitis—Mitoxantrone—breast cancer	4.26e-05	0.000252	CcSEcCtD
Buspirone—Dermatitis—Irinotecan—breast cancer	4.26e-05	0.000252	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Docetaxel—breast cancer	4.26e-05	0.000252	CcSEcCtD
Buspirone—Chills—Methotrexate—breast cancer	4.25e-05	0.000251	CcSEcCtD
Buspirone—Headache—Irinotecan—breast cancer	4.23e-05	0.00025	CcSEcCtD
Buspirone—Headache—Mitoxantrone—breast cancer	4.23e-05	0.00025	CcSEcCtD
Buspirone—Hypotension—Capecitabine—breast cancer	4.23e-05	0.00025	CcSEcCtD
Buspirone—Insomnia—Docetaxel—breast cancer	4.22e-05	0.00025	CcSEcCtD
Buspirone—Paraesthesia—Docetaxel—breast cancer	4.19e-05	0.000248	CcSEcCtD
Buspirone—Alopecia—Methotrexate—breast cancer	4.19e-05	0.000248	CcSEcCtD
Buspirone—Vomiting—Gemcitabine—breast cancer	4.18e-05	0.000247	CcSEcCtD
Buspirone—Bradycardia—Doxorubicin—breast cancer	4.18e-05	0.000247	CcSEcCtD
Buspirone—Dyspnoea—Docetaxel—breast cancer	4.16e-05	0.000246	CcSEcCtD
Buspirone—Somnolence—Docetaxel—breast cancer	4.15e-05	0.000246	CcSEcCtD
Buspirone—Rash—Gemcitabine—breast cancer	4.15e-05	0.000245	CcSEcCtD
Buspirone—Dermatitis—Gemcitabine—breast cancer	4.15e-05	0.000245	CcSEcCtD
Buspirone—Tinnitus—Epirubicin—breast cancer	4.13e-05	0.000244	CcSEcCtD
Buspirone—Erythema—Methotrexate—breast cancer	4.12e-05	0.000244	CcSEcCtD
Buspirone—Haemoglobin—Doxorubicin—breast cancer	4.12e-05	0.000244	CcSEcCtD
Buspirone—Headache—Gemcitabine—breast cancer	4.12e-05	0.000244	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Capecitabine—breast cancer	4.12e-05	0.000244	CcSEcCtD
Buspirone—Flushing—Epirubicin—breast cancer	4.12e-05	0.000243	CcSEcCtD
Buspirone—Vomiting—Fluorouracil—breast cancer	4.11e-05	0.000243	CcSEcCtD
Buspirone—Dyspepsia—Docetaxel—breast cancer	4.11e-05	0.000243	CcSEcCtD
Buspirone—Haemorrhage—Doxorubicin—breast cancer	4.1e-05	0.000243	CcSEcCtD
Buspirone—Insomnia—Capecitabine—breast cancer	4.09e-05	0.000242	CcSEcCtD
Buspirone—Hypoaesthesia—Doxorubicin—breast cancer	4.08e-05	0.000241	CcSEcCtD
Buspirone—Rash—Fluorouracil—breast cancer	4.08e-05	0.000241	CcSEcCtD
Buspirone—Dermatitis—Fluorouracil—breast cancer	4.08e-05	0.000241	CcSEcCtD
Buspirone—Paraesthesia—Capecitabine—breast cancer	4.06e-05	0.00024	CcSEcCtD
Buspirone—Decreased appetite—Docetaxel—breast cancer	4.06e-05	0.00024	CcSEcCtD
Buspirone—Hypersensitivity—Paclitaxel—breast cancer	4.06e-05	0.00024	CcSEcCtD
Buspirone—Headache—Fluorouracil—breast cancer	4.05e-05	0.00024	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—breast cancer	4.04e-05	0.000239	CcSEcCtD
Buspirone—Gastrointestinal disorder—Docetaxel—breast cancer	4.03e-05	0.000238	CcSEcCtD
Buspirone—Dyspnoea—Capecitabine—breast cancer	4.03e-05	0.000238	CcSEcCtD
Buspirone—Fatigue—Docetaxel—breast cancer	4.03e-05	0.000238	CcSEcCtD
Buspirone—Nausea—Irinotecan—breast cancer	4.01e-05	0.000237	CcSEcCtD
Buspirone—Nausea—Mitoxantrone—breast cancer	4.01e-05	0.000237	CcSEcCtD
Buspirone—Pain—Docetaxel—breast cancer	3.99e-05	0.000236	CcSEcCtD
Buspirone—Constipation—Docetaxel—breast cancer	3.99e-05	0.000236	CcSEcCtD
Buspirone—Dyspepsia—Capecitabine—breast cancer	3.98e-05	0.000235	CcSEcCtD
Buspirone—Chills—Epirubicin—breast cancer	3.98e-05	0.000235	CcSEcCtD
Buspirone—Asthenia—Paclitaxel—breast cancer	3.95e-05	0.000234	CcSEcCtD
Buspirone—Decreased appetite—Capecitabine—breast cancer	3.93e-05	0.000232	CcSEcCtD
Buspirone—Alopecia—Epirubicin—breast cancer	3.92e-05	0.000232	CcSEcCtD
Buspirone—Nausea—Gemcitabine—breast cancer	3.91e-05	0.000231	CcSEcCtD
Buspirone—Gastrointestinal disorder—Capecitabine—breast cancer	3.9e-05	0.000231	CcSEcCtD
Buspirone—Fatigue—Capecitabine—breast cancer	3.9e-05	0.000231	CcSEcCtD
Buspirone—Pruritus—Paclitaxel—breast cancer	3.9e-05	0.000231	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—breast cancer	3.89e-05	0.00023	CcSEcCtD
Buspirone—Constipation—Capecitabine—breast cancer	3.87e-05	0.000229	CcSEcCtD
Buspirone—Pain—Capecitabine—breast cancer	3.87e-05	0.000229	CcSEcCtD
Buspirone—Erythema—Epirubicin—breast cancer	3.86e-05	0.000228	CcSEcCtD
Buspirone—Feeling abnormal—Docetaxel—breast cancer	3.85e-05	0.000228	CcSEcCtD
Buspirone—Nausea—Fluorouracil—breast cancer	3.84e-05	0.000227	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—breast cancer	3.83e-05	0.000226	CcSEcCtD
Buspirone—Tinnitus—Doxorubicin—breast cancer	3.83e-05	0.000226	CcSEcCtD
Buspirone—Flushing—Doxorubicin—breast cancer	3.81e-05	0.000225	CcSEcCtD
Buspirone—Flatulence—Epirubicin—breast cancer	3.8e-05	0.000225	CcSEcCtD
Buspirone—Tension—Epirubicin—breast cancer	3.79e-05	0.000224	CcSEcCtD
Buspirone—Dysgeusia—Epirubicin—breast cancer	3.78e-05	0.000224	CcSEcCtD
Buspirone—Diarrhoea—Paclitaxel—breast cancer	3.77e-05	0.000223	CcSEcCtD
Buspirone—Nervousness—Epirubicin—breast cancer	3.75e-05	0.000222	CcSEcCtD
Buspirone—Feeling abnormal—Capecitabine—breast cancer	3.73e-05	0.00022	CcSEcCtD
Buspirone—Malaise—Methotrexate—breast cancer	3.72e-05	0.00022	CcSEcCtD
Buspirone—Muscle spasms—Epirubicin—breast cancer	3.71e-05	0.000219	CcSEcCtD
Buspirone—Vertigo—Methotrexate—breast cancer	3.71e-05	0.000219	CcSEcCtD
Buspirone—Body temperature increased—Docetaxel—breast cancer	3.69e-05	0.000218	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—breast cancer	3.69e-05	0.000218	CcSEcCtD
Buspirone—Chills—Doxorubicin—breast cancer	3.68e-05	0.000218	CcSEcCtD
Buspirone—Dizziness—Paclitaxel—breast cancer	3.64e-05	0.000215	CcSEcCtD
Buspirone—Vision blurred—Epirubicin—breast cancer	3.64e-05	0.000215	CcSEcCtD
Buspirone—Alopecia—Doxorubicin—breast cancer	3.63e-05	0.000214	CcSEcCtD
Buspirone—Urticaria—Capecitabine—breast cancer	3.59e-05	0.000212	CcSEcCtD
Buspirone—Ill-defined disorder—Epirubicin—breast cancer	3.58e-05	0.000212	CcSEcCtD
Buspirone—Body temperature increased—Capecitabine—breast cancer	3.57e-05	0.000211	CcSEcCtD
Buspirone—Convulsion—Methotrexate—breast cancer	3.57e-05	0.000211	CcSEcCtD
Buspirone—Erythema—Doxorubicin—breast cancer	3.57e-05	0.000211	CcSEcCtD
Buspirone—Agitation—Epirubicin—breast cancer	3.55e-05	0.00021	CcSEcCtD
Buspirone—Flatulence—Doxorubicin—breast cancer	3.52e-05	0.000208	CcSEcCtD
Buspirone—Chest pain—Methotrexate—breast cancer	3.51e-05	0.000208	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—breast cancer	3.51e-05	0.000208	CcSEcCtD
Buspirone—Myalgia—Methotrexate—breast cancer	3.51e-05	0.000208	CcSEcCtD
Buspirone—Tension—Doxorubicin—breast cancer	3.5e-05	0.000207	CcSEcCtD
Buspirone—Vomiting—Paclitaxel—breast cancer	3.5e-05	0.000207	CcSEcCtD
Buspirone—Dysgeusia—Doxorubicin—breast cancer	3.5e-05	0.000207	CcSEcCtD
Buspirone—Malaise—Epirubicin—breast cancer	3.48e-05	0.000206	CcSEcCtD
Buspirone—Rash—Paclitaxel—breast cancer	3.47e-05	0.000205	CcSEcCtD
Buspirone—Dermatitis—Paclitaxel—breast cancer	3.47e-05	0.000205	CcSEcCtD
Buspirone—Discomfort—Methotrexate—breast cancer	3.47e-05	0.000205	CcSEcCtD
Buspirone—Nervousness—Doxorubicin—breast cancer	3.47e-05	0.000205	CcSEcCtD
Buspirone—Vertigo—Epirubicin—breast cancer	3.47e-05	0.000205	CcSEcCtD
Buspirone—Syncope—Epirubicin—breast cancer	3.46e-05	0.000205	CcSEcCtD
Buspirone—Leukopenia—Epirubicin—breast cancer	3.46e-05	0.000204	CcSEcCtD
Buspirone—Headache—Paclitaxel—breast cancer	3.45e-05	0.000204	CcSEcCtD
Buspirone—Hypersensitivity—Docetaxel—breast cancer	3.44e-05	0.000203	CcSEcCtD
Buspirone—Muscle spasms—Doxorubicin—breast cancer	3.43e-05	0.000203	CcSEcCtD
Buspirone—Palpitations—Epirubicin—breast cancer	3.41e-05	0.000202	CcSEcCtD
Buspirone—Confusional state—Methotrexate—breast cancer	3.39e-05	0.000201	CcSEcCtD
Buspirone—Loss of consciousness—Epirubicin—breast cancer	3.39e-05	0.000201	CcSEcCtD
Buspirone—Vision blurred—Doxorubicin—breast cancer	3.37e-05	0.000199	CcSEcCtD
Buspirone—Asthenia—Docetaxel—breast cancer	3.35e-05	0.000198	CcSEcCtD
Buspirone—Convulsion—Epirubicin—breast cancer	3.34e-05	0.000198	CcSEcCtD
Buspirone—Hypertension—Epirubicin—breast cancer	3.33e-05	0.000197	CcSEcCtD
Buspirone—Hypersensitivity—Capecitabine—breast cancer	3.33e-05	0.000197	CcSEcCtD
Buspirone—Ill-defined disorder—Doxorubicin—breast cancer	3.31e-05	0.000196	CcSEcCtD
Buspirone—Pruritus—Docetaxel—breast cancer	3.3e-05	0.000195	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—breast cancer	3.3e-05	0.000195	CcSEcCtD
Buspirone—Arthralgia—Epirubicin—breast cancer	3.29e-05	0.000194	CcSEcCtD
Buspirone—Myalgia—Epirubicin—breast cancer	3.29e-05	0.000194	CcSEcCtD
Buspirone—Chest pain—Epirubicin—breast cancer	3.29e-05	0.000194	CcSEcCtD
Buspirone—Agitation—Doxorubicin—breast cancer	3.28e-05	0.000194	CcSEcCtD
Buspirone—Nausea—Paclitaxel—breast cancer	3.27e-05	0.000194	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—breast cancer	3.25e-05	0.000192	CcSEcCtD
Buspirone—Discomfort—Epirubicin—breast cancer	3.25e-05	0.000192	CcSEcCtD
Buspirone—Asthenia—Capecitabine—breast cancer	3.24e-05	0.000192	CcSEcCtD
Buspirone—Malaise—Doxorubicin—breast cancer	3.22e-05	0.00019	CcSEcCtD
Buspirone—Dry mouth—Epirubicin—breast cancer	3.21e-05	0.00019	CcSEcCtD
Buspirone—Vertigo—Doxorubicin—breast cancer	3.21e-05	0.00019	CcSEcCtD
Buspirone—Anorexia—Methotrexate—breast cancer	3.21e-05	0.00019	CcSEcCtD
Buspirone—Syncope—Doxorubicin—breast cancer	3.2e-05	0.000189	CcSEcCtD
Buspirone—Pruritus—Capecitabine—breast cancer	3.2e-05	0.000189	CcSEcCtD
Buspirone—Leukopenia—Doxorubicin—breast cancer	3.2e-05	0.000189	CcSEcCtD
Buspirone—Diarrhoea—Docetaxel—breast cancer	3.2e-05	0.000189	CcSEcCtD
Buspirone—Confusional state—Epirubicin—breast cancer	3.18e-05	0.000188	CcSEcCtD
Buspirone—Palpitations—Doxorubicin—breast cancer	3.16e-05	0.000187	CcSEcCtD
Buspirone—Oedema—Epirubicin—breast cancer	3.15e-05	0.000186	CcSEcCtD
Buspirone—Hypotension—Methotrexate—breast cancer	3.15e-05	0.000186	CcSEcCtD
Buspirone—Loss of consciousness—Doxorubicin—breast cancer	3.14e-05	0.000186	CcSEcCtD
Buspirone—Shock—Epirubicin—breast cancer	3.1e-05	0.000183	CcSEcCtD
Buspirone—Convulsion—Doxorubicin—breast cancer	3.09e-05	0.000183	CcSEcCtD
Buspirone—Diarrhoea—Capecitabine—breast cancer	3.09e-05	0.000183	CcSEcCtD
Buspirone—Dizziness—Docetaxel—breast cancer	3.09e-05	0.000183	CcSEcCtD
Buspirone—Thrombocytopenia—Epirubicin—breast cancer	3.08e-05	0.000182	CcSEcCtD
Buspirone—Hypertension—Doxorubicin—breast cancer	3.08e-05	0.000182	CcSEcCtD
Buspirone—Tachycardia—Epirubicin—breast cancer	3.07e-05	0.000182	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Methotrexate—breast cancer	3.07e-05	0.000181	CcSEcCtD
Buspirone—Hyperhidrosis—Epirubicin—breast cancer	3.05e-05	0.00018	CcSEcCtD
Buspirone—Insomnia—Methotrexate—breast cancer	3.04e-05	0.00018	CcSEcCtD
Buspirone—Chest pain—Doxorubicin—breast cancer	3.04e-05	0.00018	CcSEcCtD
Buspirone—Myalgia—Doxorubicin—breast cancer	3.04e-05	0.00018	CcSEcCtD
Buspirone—Arthralgia—Doxorubicin—breast cancer	3.04e-05	0.00018	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—breast cancer	3.02e-05	0.000179	CcSEcCtD
Buspirone—Discomfort—Doxorubicin—breast cancer	3e-05	0.000178	CcSEcCtD
Buspirone—Anorexia—Epirubicin—breast cancer	3e-05	0.000178	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—breast cancer	3e-05	0.000177	CcSEcCtD
Buspirone—Somnolence—Methotrexate—breast cancer	2.99e-05	0.000177	CcSEcCtD
Buspirone—Dizziness—Capecitabine—breast cancer	2.99e-05	0.000177	CcSEcCtD
Buspirone—Dry mouth—Doxorubicin—breast cancer	2.97e-05	0.000176	CcSEcCtD
Buspirone—Vomiting—Docetaxel—breast cancer	2.97e-05	0.000176	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—breast cancer	2.96e-05	0.000175	CcSEcCtD
Buspirone—Rash—Docetaxel—breast cancer	2.95e-05	0.000174	CcSEcCtD
Buspirone—Hypotension—Epirubicin—breast cancer	2.94e-05	0.000174	CcSEcCtD
Buspirone—Dermatitis—Docetaxel—breast cancer	2.94e-05	0.000174	CcSEcCtD
Buspirone—Confusional state—Doxorubicin—breast cancer	2.94e-05	0.000174	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—breast cancer	2.93e-05	0.000173	CcSEcCtD
Buspirone—Headache—Docetaxel—breast cancer	2.93e-05	0.000173	CcSEcCtD
Buspirone—Oedema—Doxorubicin—breast cancer	2.92e-05	0.000172	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—breast cancer	2.91e-05	0.000172	CcSEcCtD
Buspirone—Fatigue—Methotrexate—breast cancer	2.9e-05	0.000172	CcSEcCtD
Buspirone—Pain—Methotrexate—breast cancer	2.88e-05	0.00017	CcSEcCtD
Buspirone—Vomiting—Capecitabine—breast cancer	2.88e-05	0.00017	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.87e-05	0.00017	CcSEcCtD
Buspirone—Shock—Doxorubicin—breast cancer	2.87e-05	0.00017	CcSEcCtD
Buspirone—Thrombocytopenia—Doxorubicin—breast cancer	2.85e-05	0.000169	CcSEcCtD
Buspirone—Rash—Capecitabine—breast cancer	2.85e-05	0.000169	CcSEcCtD
Buspirone—Insomnia—Epirubicin—breast cancer	2.85e-05	0.000168	CcSEcCtD
Buspirone—Dermatitis—Capecitabine—breast cancer	2.85e-05	0.000168	CcSEcCtD
Buspirone—Tachycardia—Doxorubicin—breast cancer	2.85e-05	0.000168	CcSEcCtD
Buspirone—Headache—Capecitabine—breast cancer	2.83e-05	0.000168	CcSEcCtD
Buspirone—Paraesthesia—Epirubicin—breast cancer	2.83e-05	0.000167	CcSEcCtD
Buspirone—Hyperhidrosis—Doxorubicin—breast cancer	2.82e-05	0.000167	CcSEcCtD
Buspirone—Dyspnoea—Epirubicin—breast cancer	2.81e-05	0.000166	CcSEcCtD
Buspirone—Somnolence—Epirubicin—breast cancer	2.8e-05	0.000166	CcSEcCtD
Buspirone—Anorexia—Doxorubicin—breast cancer	2.78e-05	0.000164	CcSEcCtD
Buspirone—Nausea—Docetaxel—breast cancer	2.77e-05	0.000164	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—breast cancer	2.77e-05	0.000164	CcSEcCtD
Buspirone—Dyspepsia—Epirubicin—breast cancer	2.77e-05	0.000164	CcSEcCtD
Buspirone—Decreased appetite—Epirubicin—breast cancer	2.74e-05	0.000162	CcSEcCtD
Buspirone—Hypotension—Doxorubicin—breast cancer	2.72e-05	0.000161	CcSEcCtD
Buspirone—Gastrointestinal disorder—Epirubicin—breast cancer	2.72e-05	0.000161	CcSEcCtD
Buspirone—Fatigue—Epirubicin—breast cancer	2.72e-05	0.000161	CcSEcCtD
Buspirone—Pain—Epirubicin—breast cancer	2.69e-05	0.000159	CcSEcCtD
Buspirone—Constipation—Epirubicin—breast cancer	2.69e-05	0.000159	CcSEcCtD
Buspirone—Nausea—Capecitabine—breast cancer	2.69e-05	0.000159	CcSEcCtD
Buspirone—Urticaria—Methotrexate—breast cancer	2.67e-05	0.000158	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—breast cancer	2.66e-05	0.000157	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.66e-05	0.000157	CcSEcCtD
Buspirone—Insomnia—Doxorubicin—breast cancer	2.64e-05	0.000156	CcSEcCtD
Buspirone—Paraesthesia—Doxorubicin—breast cancer	2.62e-05	0.000155	CcSEcCtD
Buspirone—Dyspnoea—Doxorubicin—breast cancer	2.6e-05	0.000154	CcSEcCtD
Buspirone—Feeling abnormal—Epirubicin—breast cancer	2.6e-05	0.000154	CcSEcCtD
Buspirone—Somnolence—Doxorubicin—breast cancer	2.59e-05	0.000153	CcSEcCtD
Buspirone—Dyspepsia—Doxorubicin—breast cancer	2.57e-05	0.000152	CcSEcCtD
Buspirone—Decreased appetite—Doxorubicin—breast cancer	2.53e-05	0.00015	CcSEcCtD
Buspirone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.52e-05	0.000149	CcSEcCtD
Buspirone—Fatigue—Doxorubicin—breast cancer	2.51e-05	0.000149	CcSEcCtD
Buspirone—Urticaria—Epirubicin—breast cancer	2.5e-05	0.000148	CcSEcCtD
Buspirone—Pain—Doxorubicin—breast cancer	2.49e-05	0.000147	CcSEcCtD
Buspirone—Constipation—Doxorubicin—breast cancer	2.49e-05	0.000147	CcSEcCtD
Buspirone—Body temperature increased—Epirubicin—breast cancer	2.49e-05	0.000147	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—breast cancer	2.48e-05	0.000147	CcSEcCtD
Buspirone—Asthenia—Methotrexate—breast cancer	2.42e-05	0.000143	CcSEcCtD
Buspirone—Feeling abnormal—Doxorubicin—breast cancer	2.4e-05	0.000142	CcSEcCtD
Buspirone—Pruritus—Methotrexate—breast cancer	2.38e-05	0.000141	CcSEcCtD
Buspirone—Hypersensitivity—Epirubicin—breast cancer	2.32e-05	0.000137	CcSEcCtD
Buspirone—Urticaria—Doxorubicin—breast cancer	2.32e-05	0.000137	CcSEcCtD
Buspirone—Body temperature increased—Doxorubicin—breast cancer	2.3e-05	0.000136	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—breast cancer	2.3e-05	0.000136	CcSEcCtD
Buspirone—Asthenia—Epirubicin—breast cancer	2.26e-05	0.000134	CcSEcCtD
Buspirone—Pruritus—Epirubicin—breast cancer	2.23e-05	0.000132	CcSEcCtD
Buspirone—Dizziness—Methotrexate—breast cancer	2.23e-05	0.000132	CcSEcCtD
Buspirone—Diarrhoea—Epirubicin—breast cancer	2.16e-05	0.000127	CcSEcCtD
Buspirone—Hypersensitivity—Doxorubicin—breast cancer	2.15e-05	0.000127	CcSEcCtD
Buspirone—Vomiting—Methotrexate—breast cancer	2.14e-05	0.000127	CcSEcCtD
Buspirone—Rash—Methotrexate—breast cancer	2.12e-05	0.000126	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—breast cancer	2.12e-05	0.000125	CcSEcCtD
Buspirone—Headache—Methotrexate—breast cancer	2.11e-05	0.000125	CcSEcCtD
Buspirone—Asthenia—Doxorubicin—breast cancer	2.09e-05	0.000124	CcSEcCtD
Buspirone—Dizziness—Epirubicin—breast cancer	2.08e-05	0.000123	CcSEcCtD
Buspirone—Pruritus—Doxorubicin—breast cancer	2.06e-05	0.000122	CcSEcCtD
Buspirone—Vomiting—Epirubicin—breast cancer	2e-05	0.000118	CcSEcCtD
Buspirone—Nausea—Methotrexate—breast cancer	2e-05	0.000118	CcSEcCtD
Buspirone—Diarrhoea—Doxorubicin—breast cancer	1.99e-05	0.000118	CcSEcCtD
Buspirone—Rash—Epirubicin—breast cancer	1.99e-05	0.000117	CcSEcCtD
Buspirone—Dermatitis—Epirubicin—breast cancer	1.98e-05	0.000117	CcSEcCtD
Buspirone—Headache—Epirubicin—breast cancer	1.97e-05	0.000117	CcSEcCtD
Buspirone—Dizziness—Doxorubicin—breast cancer	1.93e-05	0.000114	CcSEcCtD
Buspirone—Nausea—Epirubicin—breast cancer	1.87e-05	0.000111	CcSEcCtD
Buspirone—Vomiting—Doxorubicin—breast cancer	1.85e-05	0.00011	CcSEcCtD
Buspirone—Rash—Doxorubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Buspirone—Dermatitis—Doxorubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Buspirone—Headache—Doxorubicin—breast cancer	1.83e-05	0.000108	CcSEcCtD
Buspirone—Nausea—Doxorubicin—breast cancer	1.73e-05	0.000102	CcSEcCtD
Buspirone—HTR2B—Signaling Pathways—CTNNB1—breast cancer	3e-06	4.78e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TYMS—breast cancer	2.99e-06	4.76e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOS3—breast cancer	2.97e-06	4.74e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP1A1—breast cancer	2.97e-06	4.73e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—MAPK3—breast cancer	2.96e-06	4.72e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BRAF—breast cancer	2.95e-06	4.71e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1B—breast cancer	2.95e-06	4.71e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NCOR1—breast cancer	2.95e-06	4.71e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.95e-06	4.71e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTM1—breast cancer	2.95e-06	4.71e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ERCC2—breast cancer	2.95e-06	4.7e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—breast cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1A—breast cancer	2.93e-06	4.67e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTEN—breast cancer	2.92e-06	4.66e-05	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—AKT1—breast cancer	2.92e-06	4.66e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BRAF—breast cancer	2.91e-06	4.63e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CASP3—breast cancer	2.9e-06	4.61e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL2—breast cancer	2.89e-06	4.61e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF1—breast cancer	2.88e-06	4.59e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL6—breast cancer	2.88e-06	4.58e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT2—breast cancer	2.88e-06	4.58e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP17A1—breast cancer	2.87e-06	4.57e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—breast cancer	2.86e-06	4.56e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK8—breast cancer	2.86e-06	4.56e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—AKT1—breast cancer	2.85e-06	4.55e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO1—breast cancer	2.84e-06	4.53e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS1—breast cancer	2.84e-06	4.53e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF1—breast cancer	2.83e-06	4.51e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	2.83e-06	4.51e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT2—breast cancer	2.83e-06	4.51e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GPX1—breast cancer	2.83e-06	4.51e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTEN—breast cancer	2.82e-06	4.5e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MDM2—breast cancer	2.82e-06	4.49e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—breast cancer	2.82e-06	4.49e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—breast cancer	2.82e-06	4.49e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—JUN—breast cancer	2.81e-06	4.48e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RAF1—breast cancer	2.81e-06	4.48e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP1A1—breast cancer	2.8e-06	4.46e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RELA—breast cancer	2.8e-06	4.46e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CTNNB1—breast cancer	2.79e-06	4.45e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP2D6—breast cancer	2.79e-06	4.44e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ERBB2—breast cancer	2.78e-06	4.43e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ERCC2—breast cancer	2.78e-06	4.43e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MTHFR—breast cancer	2.77e-06	4.41e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CD—breast cancer	2.76e-06	4.4e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MTOR—breast cancer	2.74e-06	4.37e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CB—breast cancer	2.74e-06	4.37e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	2.74e-06	4.36e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—breast cancer	2.74e-06	4.36e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NCOA2—breast cancer	2.73e-06	4.36e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SERPINE1—breast cancer	2.73e-06	4.36e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1A—breast cancer	2.73e-06	4.34e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTEN—breast cancer	2.72e-06	4.34e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CD—breast cancer	2.72e-06	4.33e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CD—breast cancer	2.71e-06	4.32e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SRC—breast cancer	2.71e-06	4.32e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—KRAS—breast cancer	2.71e-06	4.31e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	2.69e-06	4.29e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SERPINE1—breast cancer	2.69e-06	4.29e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ALB—breast cancer	2.68e-06	4.27e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—KRAS—breast cancer	2.66e-06	4.24e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK8—breast cancer	2.66e-06	4.24e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—AKT1—breast cancer	2.65e-06	4.23e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—FASN—breast cancer	2.65e-06	4.23e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—BCHE—breast cancer	2.64e-06	4.21e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—breast cancer	2.64e-06	4.21e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—breast cancer	2.64e-06	4.2e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRAS—breast cancer	2.62e-06	4.17e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—breast cancer	2.61e-06	4.17e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MTHFR—breast cancer	2.61e-06	4.16e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOS3—breast cancer	2.61e-06	4.16e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC5A5—breast cancer	2.61e-06	4.16e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1B—breast cancer	2.57e-06	4.1e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOS3—breast cancer	2.57e-06	4.09e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NOS3—breast cancer	2.56e-06	4.08e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CAV1—breast cancer	2.55e-06	4.07e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—AKT1—breast cancer	2.55e-06	4.06e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CASP3—breast cancer	2.52e-06	4.02e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SRC—breast cancer	2.52e-06	4.02e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL2—breast cancer	2.52e-06	4.02e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NQO1—breast cancer	2.52e-06	4.01e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC2A1—breast cancer	2.52e-06	4.01e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL6—breast cancer	2.51e-06	4e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK3—breast cancer	2.5e-06	3.98e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CA—breast cancer	2.49e-06	3.96e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MDM2—breast cancer	2.48e-06	3.95e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RAF1—breast cancer	2.47e-06	3.93e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—breast cancer	2.46e-06	3.92e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RELA—breast cancer	2.46e-06	3.91e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—breast cancer	2.46e-06	3.91e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—JUN—breast cancer	2.45e-06	3.91e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	2.45e-06	3.9e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ERBB2—breast cancer	2.44e-06	3.89e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MDM2—breast cancer	2.44e-06	3.88e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—breast cancer	2.43e-06	3.88e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CTNNB1—breast cancer	2.43e-06	3.88e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—breast cancer	2.43e-06	3.87e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RAF1—breast cancer	2.43e-06	3.87e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TGFB1—breast cancer	2.42e-06	3.86e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RELA—breast cancer	2.42e-06	3.85e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP1B1—breast cancer	2.42e-06	3.85e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MTOR—breast cancer	2.41e-06	3.84e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CB—breast cancer	2.41e-06	3.84e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CAV1—breast cancer	2.41e-06	3.84e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ERBB2—breast cancer	2.4e-06	3.83e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—breast cancer	2.38e-06	3.8e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—breast cancer	2.38e-06	3.79e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1A—breast cancer	2.38e-06	3.79e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTEN—breast cancer	2.37e-06	3.78e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CB—breast cancer	2.37e-06	3.78e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MTOR—breast cancer	2.37e-06	3.78e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.37e-06	3.77e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CB—breast cancer	2.36e-06	3.77e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—breast cancer	2.34e-06	3.73e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CG—breast cancer	2.33e-06	3.71e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK3—breast cancer	2.32e-06	3.7e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK8—breast cancer	2.32e-06	3.7e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—breast cancer	2.31e-06	3.69e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—AKT1—breast cancer	2.31e-06	3.69e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NCOA1—breast cancer	2.3e-06	3.67e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRAS—breast cancer	2.3e-06	3.67e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—breast cancer	2.28e-06	3.63e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—STK11—breast cancer	2.27e-06	3.62e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP19A1—breast cancer	2.27e-06	3.62e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRAS—breast cancer	2.26e-06	3.61e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—breast cancer	2.26e-06	3.6e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1B—breast cancer	2.26e-06	3.6e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TGFB1—breast cancer	2.25e-06	3.59e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KRAS—breast cancer	2.24e-06	3.58e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—AKT1—breast cancer	2.24e-06	3.56e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1B—breast cancer	2.22e-06	3.54e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CASP3—breast cancer	2.22e-06	3.53e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL2—breast cancer	2.21e-06	3.53e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—breast cancer	2.21e-06	3.52e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL6—breast cancer	2.2e-06	3.51e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—AKT1—breast cancer	2.2e-06	3.51e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SRC—breast cancer	2.2e-06	3.5e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CG—breast cancer	2.19e-06	3.49e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CASP3—breast cancer	2.18e-06	3.47e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL2—breast cancer	2.18e-06	3.47e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL6—breast cancer	2.17e-06	3.45e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—breast cancer	2.16e-06	3.44e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JUN—breast cancer	2.15e-06	3.43e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.14e-06	3.41e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.14e-06	3.4e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—breast cancer	2.12e-06	3.38e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—breast cancer	2.12e-06	3.38e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JUN—breast cancer	2.12e-06	3.37e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—COMT—breast cancer	2.11e-06	3.36e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.1e-06	3.35e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTP1—breast cancer	2.1e-06	3.35e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—breast cancer	2.09e-06	3.34e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KRAS—breast cancer	2.09e-06	3.33e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.09e-06	3.32e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTEN—breast cancer	2.08e-06	3.32e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HMOX1—breast cancer	2.07e-06	3.3e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ITPR1—breast cancer	2.07e-06	3.3e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	3.29e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—breast cancer	2.06e-06	3.28e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.05e-06	3.27e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTEN—breast cancer	2.05e-06	3.26e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CD—breast cancer	2.05e-06	3.26e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTEN—breast cancer	2.04e-06	3.25e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK8—breast cancer	2.04e-06	3.25e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—AKT1—breast cancer	2.03e-06	3.24e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.03e-06	3.23e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALB—breast cancer	2.02e-06	3.22e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK8—breast cancer	2e-06	3.19e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—AKT1—breast cancer	2e-06	3.18e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—breast cancer	2e-06	3.18e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CA—breast cancer	1.99e-06	3.18e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCB1—breast cancer	1.99e-06	3.17e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—breast cancer	1.97e-06	3.14e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.97e-06	3.13e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMS—breast cancer	1.95e-06	3.11e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NOS3—breast cancer	1.93e-06	3.08e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.93e-06	3.08e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NCOR1—breast cancer	1.93e-06	3.08e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTM1—breast cancer	1.93e-06	3.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SRC—breast cancer	1.93e-06	3.08e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.93e-06	3.07e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—breast cancer	1.93e-06	3.07e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.92e-06	3.06e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRAS—breast cancer	1.91e-06	3.04e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALB—breast cancer	1.9e-06	3.03e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SRC—breast cancer	1.9e-06	3.03e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—breast cancer	1.88e-06	3e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—breast cancer	1.86e-06	2.97e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—breast cancer	1.86e-06	2.96e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.85e-06	2.95e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GPX1—breast cancer	1.85e-06	2.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—breast cancer	1.83e-06	2.92e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.83e-06	2.92e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL6—breast cancer	1.83e-06	2.91e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NOS3—breast cancer	1.82e-06	2.9e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KRAS—breast cancer	1.82e-06	2.9e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ERCC2—breast cancer	1.82e-06	2.89e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CB—breast cancer	1.78e-06	2.84e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK3—breast cancer	1.78e-06	2.83e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRAS—breast cancer	1.78e-06	2.83e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—breast cancer	1.77e-06	2.82e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.75e-06	2.79e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—breast cancer	1.73e-06	2.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TGFB1—breast cancer	1.73e-06	2.75e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MTHFR—breast cancer	1.71e-06	2.72e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—breast cancer	1.7e-06	2.71e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL6—breast cancer	1.7e-06	2.71e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.7e-06	2.71e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—breast cancer	1.69e-06	2.7e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—AKT1—breast cancer	1.68e-06	2.68e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.68e-06	2.68e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.67e-06	2.67e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—breast cancer	1.66e-06	2.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—breast cancer	1.66e-06	2.65e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AKT1—breast cancer	1.63e-06	2.59e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—breast cancer	1.62e-06	2.58e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KRAS—breast cancer	1.6e-06	2.55e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CAV1—breast cancer	1.57e-06	2.51e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KRAS—breast cancer	1.57e-06	2.51e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—AKT1—breast cancer	1.57e-06	2.5e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRAS—breast cancer	1.55e-06	2.47e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTEN—breast cancer	1.54e-06	2.46e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL6—breast cancer	1.48e-06	2.36e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.47e-06	2.34e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTEN—breast cancer	1.45e-06	2.31e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.44e-06	2.3e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CA—breast cancer	1.44e-06	2.3e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.43e-06	2.28e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—breast cancer	1.42e-06	2.26e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—breast cancer	1.4e-06	2.23e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AKT1—breast cancer	1.37e-06	2.18e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRAS—breast cancer	1.36e-06	2.17e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRAS—breast cancer	1.34e-06	2.13e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6—breast cancer	1.3e-06	2.07e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6—breast cancer	1.28e-06	2.04e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CD—breast cancer	1.26e-06	2.01e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALB—breast cancer	1.24e-06	1.98e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT1—breast cancer	1.2e-06	1.91e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NOS3—breast cancer	1.19e-06	1.9e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT1—breast cancer	1.18e-06	1.88e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AKT1—breast cancer	1.18e-06	1.88e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.1e-06	1.75e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—breast cancer	1.09e-06	1.73e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CA—breast cancer	1.09e-06	1.73e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.02e-06	1.63e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTEN—breast cancer	9.49e-07	1.51e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AKT1—breast cancer	8.88e-07	1.42e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AKT1—breast cancer	8.37e-07	1.33e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CA—breast cancer	6.7e-07	1.07e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AKT1—breast cancer	5.47e-07	8.72e-06	CbGpPWpGaD
